The trajectory of Viagra presents a nuanced case for stakeholders in the pharmaceutical sector. While initially a phenomenal success, generating vast sums, the patent lapse and the subsequent flood of cheaper versions https://adult445791.dm-blog.com/42106065/sildenafil-and-big-pharma-a-hazardous-investment